Price movement over the last 24 hours
Acadia Healthcare Company Inc vs Nano Dimension Ltd - ADR — how do they compare? Acadia Healthcare Company Inc trades at $30.61 (market cap $2.94B), while Nano Dimension Ltd - ADR trades at $1.51 (market cap $307.34M). The key difference: Acadia Healthcare Company Inc is far larger — about 9.6× Nano Dimension Ltd - ADR's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| ACHC | NNDM | |
|---|---|---|
Market Cap | $2.94B | $307.34M |
Sector | Health | Technology |
52-Week High | $31.92 | $2.14 |
52-Week Low | $11.68 | $1.21 |
Enterprise Value | $5.45B | -$102.00M |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Nano Dimension (NNDM) trades at $1.46, up 0.69% on the day, with a bullish technical signal but bearish moving averages. The company reported Q1 2026 revenue of $102.44M but a net loss of $293.30M, with negative cash flow from operations of $101.28M. Recent news highlights a proposed business combination with Infinite Epigenetics and ongoing shareholder disputes with Murchinson Ltd., reflecting strategic shifts and internal tensions.
Outlook remains challenged by persistent losses and cash burn, though the low P/B of 0.63 may attract value investors. Key risks include execution of the strategic plan, shareholder approval of the Infinite Epigenetics deal, and achieving profitability. Opportunities lie in cost reductions and potential synergies from mergers, but the stock faces significant fundamental headwinds.
Trailing returns across standard periods
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →